Corrigendum to: Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax (Biomedical Chromatography, (2022), 36, 3, 10.1002/bmc.5289)

Susan C. Scott; Nicole M. Anders; Ping He; Avelina Hemingway; Steven D. Gore; Christine L. Hann; Michelle A. Rudek

doi:10.1002/bmc.5383

Corrigendum to: Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax (Biomedical Chromatography, (2022), 36, 3, 10.1002/bmc.5289)

Susan C. Scott, Nicole M. Anders, Ping He, Avelina Hemingway, Steven D. Gore, Christine L. Hann, Michelle A. Rudek

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

There were some errors in this paper when it was first published. Throughout the paper, “34 months” have been changed to “43 months”. Table 1 has been corrected as it appears below: 1 TABLE Validation characteristics of navitoclax (Table presented.) These errors have now been corrected online.

Original language	English (US)
Article number	e5383
Journal	Biomedical Chromatography
Volume	36
Issue number	6
DOIs	https://doi.org/10.1002/bmc.5383
State	Published - Jun 2022

ASJC Scopus subject areas

Drug Discovery
Analytical Chemistry
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmacology

Access to Document

10.1002/bmc.5383

Fingerprint

Dive into the research topics of 'Corrigendum to: Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax (Biomedical Chromatography, (2022), 36, 3, 10.1002/bmc.5289)'. Together they form a unique fingerprint.

Cite this

Scott, S. C., Anders, N. M., He, P., Hemingway, A., Gore, S. D., Hann, C. L., & Rudek, M. A. (2022). Corrigendum to: Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax (Biomedical Chromatography, (2022), 36, 3, 10.1002/bmc.5289). Biomedical Chromatography, 36(6), Article e5383. https://doi.org/10.1002/bmc.5383

Corrigendum to: Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax (Biomedical Chromatography, (2022), 36, 3, 10.1002/bmc.5289). / Scott, Susan C.; Anders, Nicole M.; He, Ping et al.
In: Biomedical Chromatography, Vol. 36, No. 6, e5383, 06.2022.

Research output: Contribution to journal › Comment/debate › peer-review

Scott, SC, Anders, NM, He, P, Hemingway, A, Gore, SD, Hann, CL & Rudek, MA 2022, 'Corrigendum to: Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax (Biomedical Chromatography, (2022), 36, 3, 10.1002/bmc.5289)', Biomedical Chromatography, vol. 36, no. 6, e5383. https://doi.org/10.1002/bmc.5383

@article{3032ca0bfaed42a497d7fdc5d842583b,

title = "Corrigendum to: Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax (Biomedical Chromatography, (2022), 36, 3, 10.1002/bmc.5289)",

abstract = "There were some errors in this paper when it was first published. Throughout the paper, “34 months” have been changed to “43 months”. Table 1 has been corrected as it appears below: 1 TABLE Validation characteristics of navitoclax (Table presented.) These errors have now been corrected online.",

author = "Scott, {Susan C.} and Anders, {Nicole M.} and Ping He and Avelina Hemingway and Gore, {Steven D.} and Hann, {Christine L.} and Rudek, {Michelle A.}",

note = "Publisher Copyright: {\textcopyright} 2022 John Wiley & Sons, Ltd.",

year = "2022",

month = jun,

doi = "10.1002/bmc.5383",

language = "English (US)",

volume = "36",

journal = "Biomedical Chromatography",

issn = "0269-3879",

publisher = "John Wiley and Sons Ltd",

number = "6",

}

TY - JOUR

T1 - Corrigendum to

T2 - Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax (Biomedical Chromatography, (2022), 36, 3, 10.1002/bmc.5289)

AU - Scott, Susan C.

AU - Anders, Nicole M.

AU - He, Ping

AU - Hemingway, Avelina

AU - Gore, Steven D.

AU - Hann, Christine L.

AU - Rudek, Michelle A.

PY - 2022/6

Y1 - 2022/6

N2 - There were some errors in this paper when it was first published. Throughout the paper, “34 months” have been changed to “43 months”. Table 1 has been corrected as it appears below: 1 TABLE Validation characteristics of navitoclax (Table presented.) These errors have now been corrected online.

AB - There were some errors in this paper when it was first published. Throughout the paper, “34 months” have been changed to “43 months”. Table 1 has been corrected as it appears below: 1 TABLE Validation characteristics of navitoclax (Table presented.) These errors have now been corrected online.

UR - http://www.scopus.com/inward/record.url?scp=85128167241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85128167241&partnerID=8YFLogxK

U2 - 10.1002/bmc.5383

DO - 10.1002/bmc.5383

M3 - Comment/debate

C2 - 35434828

AN - SCOPUS:85128167241

SN - 0269-3879

VL - 36

JO - Biomedical Chromatography

JF - Biomedical Chromatography

IS - 6

M1 - e5383

ER -

Corrigendum to: Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax (Biomedical Chromatography, (2022), 36, 3, 10.1002/bmc.5289)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this